Your weekly listens from Road2Wellbeing Podcast, Helping HR Leaders Guide Their Workforce to Wellness
GLP-1s are already in your workforce.
One in eight American adults has now used a GLP-1. Most accessed it through a telehealth form with no clinical guardrails and no lifestyle support. This drug suppresses appetite without building the habits that make results last. Without employer-side infrastructure, you’re looking at muscle loss, nutrient deficiencies, and a yo-yo cycle that drives future health claims. The wellness side is where the gaps get filled.
What we discuss
- Why GLP-1s have reached mainstream scale and what the public conversation is missing
- The clinical risks nobody is talking about: muscle loss, nutrient deficiencies, no guardrails
- What the drug does to the body beyond the number on the scale
- Why lifestyle habits have to be built alongside the medication, not after
- What lasting support actually looks like: movement, nutrition, behavior change
- Why HR leaders should care and what they can do about it
- The business case: today’s deficiencies become tomorrow’s health claims
- How to actually start a GLP-1 journey the right way
Referenced in this episode
- Wellness360: Enterprise wellness platform wellness360.co
- KFF Health Tracking Poll (2024): 1 in 8 American adults have used a GLP-1 medication
- Transtheoretical Model of Behavior Change: The framework Samantha references for maintenance-stage support
- NCQA Wellness Program Accreditation: The clinical quality standard Wellness360 is accredited under ncqa.org
Brought to you by — Wellness360, an NCQA-accredited, HiTrust-r2 certified, enterprise wellness platform built on the 8 Pillars of Wellness. Bringing you clinical depth and seamless HRIS integration while recording upto 70% sustained employee engagement.
Listen to this episode and more on https://www.wellness360.co/podcasts/road2wellbeing-s2e001/
